Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb;81(2):178-85.
doi: 10.1007/s12098-013-1280-8. Epub 2013 Nov 20.

Congenital adrenal hyperplasia: issues in diagnosis and treatment in children

Rajni Sharma  1 , Anju Seth
Affiliations
Review

Congenital adrenal hyperplasia: issues in diagnosis and treatment in children

Rajni Sharma et al. Indian J Pediatr. 2014 Feb.

Abstract

Congenital adrenal hyperplasia (CAH) is a common disorder of impaired adrenal cortisol biosynthesis with associated androgen excess. The clinical presentation of 21-hydroxylase deficiency, the commonest cause of CAH, forms a spectrum and can be divided into classic and non-classic types. The former consists of life threatening salt wasting and non-life threatening simple virilizing phenotypes. Patients with the non-classic form are asymptomatic or have mild features of androgen excess. Most developed countries have newborn screening facilities for CAH. In the absence of newborn screening, the diagnosis of CAH may be missed or delayed. This can result in neonatal mortality in salt wasting forms and incorrect sex of rearing in females with simple virilizing form. The diagnosis is reached by demonstrating high serum 17-hydroxyprogesterone (17OHP) levels. Preterm birth and neonatal illness can cause physiological elevation of 17OHP, thus complicating the diagnosis of CAH in the newborn period. Prenatal diagnosis and treatment with dexamethasone to prevent virilization of affected female fetuses is another area of controversy. The management of CAH is complicated by the need to use supraphysiologic doses of glucocorticoids to suppress adrenal androgen synthesis. In this review, the authors address pertinent issues related to the diagnosis and management of CAH in children.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. N Engl J Med. 2003 Aug 21;349(8):776-88 - PubMed
    1. J Clin Endocrinol Metab. 2010 Sep;95(9):4133-60 - PubMed
    1. J Urol. 2008 Feb;179(2):634-8 - PubMed
    1. J Clin Endocrinol Metab. 2003 Aug;88(8):3525-30 - PubMed
    1. J Pediatr. 2003 Sep;143(3):402-5 - PubMed

MeSH terms

Supplementary concepts

LinkOut - more resources